Human papillomavirus (HPV) is necessary for the development of cervical carcinoma, and incorporation of molecular testing for HPV in screening and patient management has been proposed. Sufficient ...

Menopause marks the end of a woman’s childbearing years, but it doesn’t mark the end of the need for a particular screening ...

Agilent Technologies Inc. (NYSE: A) today announced its PD-L1 IHC 22C3 pharmDx (Code SK006) assay has received European IVDR ...

During a live event, Shannon N. Westin, MD, MPH, and participants discussed their experience treating patients with ...

compatible with the clinical cervical carcinoma FIGO stage IB 1. Because the patient chose to terminate the pregnancy, a radical hysterectomy with the fetus in situ, with ovarian preservation and ...

The company will also present a poster on randomized Phase II data of TG4001 in combination with avelumab in the cervical cancer subgroup. The 2025 American Society of Clinical Oncology (ASCO), annual ...

Uterine carcinosarcoma, also referred to as malignant mixed Müllerian tumor, is a rare and highly aggressive neoplasm ...

Researchers used integrated Mendelian randomization in a cohort of over 247,000 individuals to identify 62 plasma proteins associated with breast cancer risk. Nine high-confidence targets, including ...

Emerging biotech leader AKESF develops Ivonescimab & Cadonilimab; while offering growth potential with US partnerships, ...

Project ECHO HPV Vaccination Series receives support in honor of UNR Med Alumnus John M. Erickson, M.D.